These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29353052)

  • 1. Evidence for altered insulin receptor signaling in Alzheimer's disease.
    Griffith CM; Eid T; Rose GM; Patrylo PR
    Neuropharmacology; 2018 Jul; 136(Pt B):202-215. PubMed ID: 29353052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal insulin in Alzheimer's disease: Food for thought.
    Chapman CD; Schiöth HB; Grillo CA; Benedict C
    Neuropharmacology; 2018 Jul; 136(Pt B):196-201. PubMed ID: 29180222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired peripheral glucose homeostasis and Alzheimer's disease.
    Wijesekara N; Gonçalves RA; De Felice FG; Fraser PE
    Neuropharmacology; 2018 Jul; 136(Pt B):172-181. PubMed ID: 29169962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
    Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
    Duarte AI; Santos MS; Oliveira CR; Moreira PI
    Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rise and fall of insulin signaling in Alzheimer's disease.
    Chami B; Steel AJ; De La Monte SM; Sutherland GT
    Metab Brain Dis; 2016 Jun; 31(3):497-515. PubMed ID: 26883429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.
    de la Monte SM; Wands JR
    J Alzheimers Dis; 2005 Feb; 7(1):45-61. PubMed ID: 15750214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease.
    Velazquez R; Tran A; Ishimwe E; Denner L; Dave N; Oddo S; Dineley KT
    Neurobiol Aging; 2017 Oct; 58():1-13. PubMed ID: 28688899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease.
    Ferreira ST; Clarke JR; Bomfim TR; De Felice FG
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S76-83. PubMed ID: 24529528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.
    Candeias E; Duarte AI; Sebastião I; Fernandes MA; Plácido AI; Carvalho C; Correia S; Santos RX; Seiça R; Santos MS; Oliveira CR; Moreira PI
    Mol Neurobiol; 2017 Oct; 54(8):6471-6489. PubMed ID: 27730513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.
    Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH
    Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of insulin in the vascular contributions to age-related dementia.
    Hughes TM; Craft S
    Biochim Biophys Acta; 2016 May; 1862(5):983-91. PubMed ID: 26657615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets.
    Vieira MNN; Lima-Filho RAS; De Felice FG
    Neuropharmacology; 2018 Jul; 136(Pt B):160-171. PubMed ID: 29129775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impairment of insulin signaling in Alzheimer's disease.
    Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
    IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Insulin Signaling for the Treatment of Alzheimer's Disease.
    Chen Y; Zhang J; Zhang B; Gong CX
    Curr Top Med Chem; 2016; 16(5):485-92. PubMed ID: 26268336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
    Calvo-Ochoa E; Arias C
    Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease.
    Meeker KD; Meabon JS; Cook DG
    J Alzheimers Dis; 2015; 45(2):509-20. PubMed ID: 25589729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications.
    Tumminia A; Vinciguerra F; Parisi M; Frittitta L
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30355995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.